Clinical study to evaluate MPDL3280A-RO5541267 in patients with PD-L1- positive locally or metastatic non-small cell lung cancer

Update Il y a 4 ans
Reference: EUCTR2013-000177-69

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary efficacy objective for this study is to evaluate the efficacy of MPDL3280A in patients with PD-L1−positive locally advanced or metastatic NSCLC, as measured by investigator-assessed ORR according to modified RECIST


Inclusion criteria

  • PD-L1-POSITIVE LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER